Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0001
0.0000
(0.00%)
At close: February 21 at 3:00:00 PM EST
Breakdown
TTM
Operating Expense
958.9350
Operating Income
-958.9350
Net Non Operating Interest Income Expense
-18.6350
Pretax Income
-977.5700
Net Income Common Stockholders
-977.5700
Diluted NI Available to Com Stockholders
-977.5700
Basic EPS
-1.78
Diluted EPS
-1.78
Total Operating Income as Reported
-958.9350
Total Expenses
958.9350
Net Income from Continuing & Discontinued Operation
-977.5700
Normalized Income
-977.5700
Interest Expense
18.6350
Net Interest Income
-18.6350
EBIT
-958.9350
EBITDA
-944.5860
Reconciled Depreciation
14.3490
Net Income from Continuing Operation Net Minority Interest
-977.5700
Normalized EBITDA
-944.5860
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BSSP Baseline Productions, Inc.
0.0001
0.00%
CUBT Curative Biotechnology, Inc.
0.0164
+32.26%
RGBP Regen BioPharma, Inc.
0.0660
-20.48%
AADI Aadi Bioscience, Inc.
2.7900
-2.45%
PHGE BiomX Inc.
0.9588
+4.92%
ENZC Enzolytics, Inc.
0.0007
-12.50%
BRTX BioRestorative Therapies, Inc.
1.8000
-8.16%
EDSA Edesa Biotech, Inc.
2.4300
-2.80%
ADPT Adaptive Biotechnologies Corporation
8.27
-0.72%
EYEN Eyenovia, Inc.
1.6800
-2.89%